Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market U.S. pharmaceutical giant Eli Lilly will give Hong Kong-listed Insilico $115 million upfront to bring some of its AI-discovered drugs to the global market.

Hong Kong-listed #InsilicoMedicine has reached a deal with U.S. pharma giant #EliLilly for #AI-discovered #drugs. The two companies have worked together since 2023. Insilico’s CEO, #Zhavoronkov, said Eli Lilly has a #competitive edge in certain aspects of AI. www.cnbc.com/2026/03/29/e...